Why Home-Use Medical Devices Require Greater Regulatory Attention

Medical care is no longer limited to hospitals, clinics, and professional healthcare facilities.

Patients increasingly use medical devices in their homes to monitor chronic conditions, administer treatments, support rehabilitation, manage pain, collect diagnostic information, and communicate health data to healthcare providers.

This transition creates meaningful benefits. Home-use technologies can improve access to care, support earlier intervention, reduce unnecessary hospital visits, and allow patients to manage their health more independently.

However, moving a medical device into the home also changes the conditions under which the device is used.

A product that performs safely and effectively in a controlled clinical setting may present different risks when operated by a patient, family member, or caregiver without direct professional supervision.

For this reason, manufacturers should not view home use as simply another sales channel. It is a distinct use environment that must be addressed throughout product development, testing, labeling, and post-market management.

The Home Is Not a Controlled Clinical Environment

Hospitals and healthcare facilities generally have trained personnel, standardized procedures, controlled environmental conditions, established cleaning protocols, backup systems, and immediate access to technical or clinical support.

A home may have none of these protections.

Home-use medical devices may be exposed to:

• Inconsistent temperature or humidity

• Poor lighting

• Background noise and distractions

• Limited electrical outlets

• Unstable internet or wireless connections

• Improper storage

• Children or pets

• Household dust, liquids, or cleaning products

• Delayed maintenance

• Unauthorized users

• Limited access to replacement parts or technical support

Manufacturers must evaluate whether these conditions could affect device performance or contribute to unsafe use.

A home-use device should therefore be assessed not only under ideal laboratory conditions, but also under reasonably foreseeable conditions of actual use.

Home Users Are Different From Healthcare Professionals

A medical device used in a hospital may be operated by a trained nurse, technician, physician, or other professional who understands clinical terminology, device alarms, contraindications, and emergency procedures.

Home users may have very different capabilities.

They may include:

• Older adults

• Children or adolescents

• Patients with impaired vision or hearing

• Users with limited dexterity

• Individuals with cognitive limitations

• Caregivers with little or no medical training

• Patients using the device while experiencing pain, anxiety, fatigue, or distress

• Users who do not speak English as their primary language

FDA’s human factors approach considers the interaction among three major components: the intended users, the intended use environments, and the device user interface. The user interface includes every element with which the user interacts, including controls, displays, alarms, accessories, packaging, labeling, instructions, setup procedures, cleaning, maintenance, and training materials.

A technically accurate device can still create serious risk if the user cannot understand its instructions, interpret its display, respond to an alarm, or recognize an incorrect setup.

Human Factors Is More Than an Instruction Manual

One common misconception is that use-related risk can be addressed by adding more warnings to the labeling.

Warnings and instructions are important, but they should not be the primary solution to a poor user interface.

Human factors and usability engineering should be incorporated into the design process so that the product itself helps prevent foreseeable errors.

Manufacturers should identify critical tasks such as:

• Setting up the device correctly

• Selecting the proper operating mode

• Entering patient information

• Positioning sensors or accessories

• Interpreting results

• Responding to alarms

• Replacing consumable components

• Charging or connecting the device

• Cleaning and disinfecting the product

• Recognizing when the device is malfunctioning

• Knowing when to contact a healthcare provider

The design team should then evaluate what could happen if each task is performed incorrectly, omitted, or misunderstood.

FDA finalized updated guidance in May 2026 describing a risk-based framework for determining what human factors information should be included in medical-device marketing submissions. The guidance is intended to complement FDA’s established usability-engineering principles and improve the consistency and efficiency of premarket review.

Over-the-Counter Does Not Automatically Mean Low Risk

Another common misunderstanding is that a device sold directly to consumers must be a low-risk Class I device.

That is not necessarily true.

FDA explains that while some over-the-counter devices are Class I, many are Class II and some may even be Class III. Class II and Class III products generally require premarket review. In addition, not every device intended for use at home is available over the counter; certain home-use devices still require a prescription.

Manufacturers should separately determine:

1. The device classification

2. The applicable premarket pathway

3. Whether the product may be sold over the counter

4. Whether professional involvement or a prescription is required

5. Whether the device has been adequately validated for lay users

A product does not become exempt from FDA requirements simply because it is portable, consumer-friendly, or used outside a hospital.

Labeling Must Work Without a Professional Present

Home-use labeling must enable the intended user to operate the device safely and effectively without relying on assumptions that may be reasonable in a clinical environment.

Instructions should clearly explain:

• Who should and should not use the device

• The device’s intended purpose

• Required setup and preparation

• Proper operating procedures

• Contraindications and warnings

• Expected results

• Alarm meanings

• Cleaning and storage

• Maintenance requirements

• Troubleshooting

• When use should be discontinued

• When professional medical assistance is necessary

The labeling should also be consistent across the package, user manual, quick-start guide, mobile application, website, training materials, and customer-support content.

A well-designed quick-start guide cannot compensate for contradictory instructions elsewhere.

Similarly, a disclaimer stating that users should consult a healthcare professional may not adequately control a risk if the device design encourages incorrect or unsupervised use.

Connected Devices Add Another Layer of Risk

Many home-use medical devices now communicate with smartphones, cloud platforms, healthcare systems, or other devices.

Connectivity may allow remote monitoring, software updates, personalized recommendations, data sharing, and communication with healthcare professionals.

It may also create cybersecurity and interoperability risks.

Potential issues include:

• Unauthorized access

• Loss or alteration of patient data

• Interrupted communication

• Incorrect data transmission

• Incompatible software versions

• Failed updates

• Dependence on a cloud service

• Use of unsupported mobile devices

• Disconnection from a network

• Incorrect operation caused by data from another system

FDA defines medical-device interoperability as the ability to safely, securely, and effectively exchange and use information among devices, products, technologies, or systems.

FDA’s current cybersecurity guidance also addresses secure device design, labeling, quality-system considerations, and the cybersecurity documentation expected in premarket submissions for devices with cybersecurity risk.

Cybersecurity should therefore be treated as part of device safety and lifecycle management—not only as an information-technology issue.

Software Updates Can Affect Regulatory Status

Connected devices often continue evolving after launch.

Manufacturers may update an application, modify an algorithm, add a feature, change the user interface, or revise how results are displayed.

Each change should be evaluated to determine whether it affects:

• Intended use

• Device performance

• Risk controls

• Critical user tasks

• Cybersecurity

• Interoperability

• Clinical functionality

• Previously completed verification or validation

• The need for a new FDA submission

A seemingly minor software update can change how a user interacts with the device or interprets its results.

Manufacturers therefore need documented change-control procedures that assess both technical and regulatory impact.

Remote Monitoring Does Not Eliminate Manufacturer Responsibility

When a device is used in the home, problems may be more difficult to identify.

Users may not recognize a malfunction. They may stop using the device without reporting the issue, contact a retailer rather than the manufacturer, or describe the problem as a general customer-service complaint.

Manufacturers should establish systems capable of identifying potential safety signals across:

• Complaints

• Returns

• Repairs

• Warranty requests

• App-store reviews

• Customer-support communications

• Distributor reports

• Adverse-event information

• Cybersecurity reports

• Software performance data

Post-market surveillance for a home-use product should consider not only device failures, but also recurring confusion, setup problems, misunderstood alarms, unsuccessful software updates, and other patterns suggesting a use-related risk.

Practical Questions for Manufacturers

Before marketing a device for home use, manufacturers should be able to answer the following:

Intended Users

• Who will operate the device?

• Are caregivers expected to assist?

• What physical, sensory, or cognitive limitations are foreseeable?

• Is the product suitable for the intended age groups?

Use Environment

• Where will the device be stored and operated?

• What environmental conditions may affect it?

• Is reliable electricity or internet access required?

• Could children, pets, liquids, or household contaminants create hazards?

User Interface

• Can users understand the controls, displays, and alarms?

• Are critical tasks clearly identified?

• Can common errors be prevented through design?

• Have representative users tested the product?

Labeling and Training

• Can the device be used correctly without professional supervision?

• Are warnings understandable and actionable?

• Are all instructions consistent?

• Is training required, and can its effectiveness be demonstrated?

Connectivity

• What happens when communication is interrupted?

• How are software updates controlled?

• How are cybersecurity vulnerabilities addressed?

• Can incorrect or delayed data lead to patient harm?

Post-Market Controls

• How will complaints and use errors be identified?

• How will users receive urgent safety information?

• Can affected devices be traced?

• How will software corrections or field actions be implemented?

The Key Regulatory Lesson

Home-use medical devices can expand access to care and provide patients with greater independence.

However, the home introduces variability that does not exist in a controlled healthcare environment.

Manufacturers must account for users who may have limited training, environments that may be unpredictable, and devices that may depend on software, wireless communication, or remote support.

The key question is not simply:

“Does the device work?”

It is:

“Can the intended user operate the device safely and effectively in the intended home environment, under reasonably foreseeable conditions?”

For a home-use medical device, safety and effectiveness depend on much more than technical performance.

They depend on the complete system: the product, the user, the environment, the instructions, the software, the connectivity, and the manufacturer’s ability to manage the device throughout its lifecycle.